Simple Amplification‐Based Assay: A Nucleic Acid–Based Point‐of‐Care Platform for HIV‐1 Testing

Abstract

The unique characteristics and competitive performance of the SAMBA HIV-1 test render it suitable for point-of-care and near-patient testing in both developed and developing countries.